Sean D. Sullivan
Pharmaceutical
Outcomes Research and Policy Program
University of Washington
Seattle
USA
Name/email consistency: high
- Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone. Sullivan, S.D., Alfonso-Cristancho, R., Conner, C., Hammer, M., Blonde, L. Cardiovasc. Diabetol (2009)
- A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. Sullivan, S.D., Alfonso-Cristancho, R., Conner, C., Hammer, M., Blonde, L. Pharmacotherapy (2009)
- Health technology assessment in health-care decisions in the United States. Sullivan, S.D., Watkins, J., Sweet, B., Ramsey, S.D. Value. Health (2009)
- The promise of specialty pharmaceuticals: are they worth the price? Sullivan, S.D. J. Manag. Care. Pharm (2008)
- Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. Sullivan, S.D., Veenstra, D.L., Chen, P.J., Chang, T.T., Chuang, W.L., Tsai, C., Patel, K. J. Gastroenterol. Hepatol. (2007)
- Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. Sullivan, S.D., Kwong, L., Nutescu, E. Value. Health (2006)
- A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Sullivan, S.D., Lee, T.A., Blough, D.K., Finkelstein, J.A., Lozano, P., Inui, T.S., Fuhlbrigge, A.L., Carey, V.J., Wagner, E., Weiss, K.B. Arch. Pediatr. Adolesc. Med (2005)
- Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C. Sullivan, S.D., Craxi, A., Alberti, A., Giuliani, G., De Carli, C., Wintfeld, N., Patel, K.K., Green, J. Pharmacoeconomics (2004)
- A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Sullivan, S.D., Davidson, B.L., Kahn, S.R., Muntz, J.E., Oster, G., Raskob, G. Pharmacoeconomics (2004)
- Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Sullivan, S.D., Kahn, S.R., Davidson, B.L., Borris, L., Bossuyt, P., Raskob, G. Pharmacoeconomics (2003)
- Exploring new frontiers in asthma management for optimal therapeutic and economic outcomes. Sullivan, S.D., Meltzer, E.O. J. Manag. Care. Pharm (2003)
- Asthma in the United States: recent trends and current status. Sullivan, S.D. J. Manag. Care. Pharm (2003)
- Emerging therapeutic strategies for asthma management. Sullivan, S.D., Meltzer, E.O. J. Manag. Care. Pharm (2003)
- Health state preference assessment in diabetic peripheral neuropathy. Sullivan, S.D., Lew, D.P., Devine, E.B., Hakim, Z., Reiber, G.E., Veenstra, D.L. Pharmacoeconomics (2002)
- The economic burden of COPD. Sullivan, S.D., Ramsey, S.D., Lee, T.A. Chest (2000)
